Characterization of TR‐107, a novel chemical activator of the human mitochondrial protease ClpP

• Ngā kaituhi matua: Emily M. J. Fennell (Author), Lucas J. Aponte‐Collazo (Author), Joshua D. Wynn (Author), Kristina Drizyte‐Miller (Author), Elisa Leung (Author), Yoshimi Endo Greer (Author), Paul R. Graves (Author), Andrew A. Iwanowicz (Author), Hani Ashamalla (Author), Ekhson Holmuhamedov (Author), Henk Lang (Author), Donald S. Karanewsky (Author), Channing J. Der (Author), Walid A. Houry (Author), Stanley Lipkowitz (Author), Edwin J. Iwanowicz (Author), Lee M. Graves (Author)
• Hōputu: Pukapuka
• I whakaputaina: Wiley, 2022-08-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Abstract We recently described the identification of a new class of small‐molecule activators of the mitochondrial protease ClpP. These compounds synthesized by Madera Therapeutics showed increased potency of cancer growth inhibition over the related compound ONC201. In this study, we describe chemi...